Clinical trials
Non-Muscle Invasive Bladder Neoplasms trials in Israel
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Recruiting | 6 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| UroGen Pharma Ltd. | 6 |
| Janssen Research & Development, LLC | 3 |
| Eli Lilly and Company | 2 |
| Anchiano Therapeutics Israel Ltd. | 1 |
| LifeBiotic Medical Research Ltd. | 1 |
| Medical Enterprises Europe B.V. | 1 |
| Pfizer | 1 |
| Relmada Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-Muscle Invasive Bladder Neoplasms | 16 |
| Urinary Bladder Neoplasms | 11 |
| Urologic Neoplasms | 5 |
| Urinary Bladder Diseases | 4 |
| Urologic Diseases | 4 |
| Neoplasms | 3 |
| Carcinoma, Transitional Cell | 2 |
| Neoplasms by Site | 2 |
| Carcinoma | 1 |
| Hyperthermia | 1 |
Trials
Showing 26 to 16 of 16. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.